Ambroxol

This procurement continues the procedures of tender No. 743831, originally published on 2024-10-24 in the old system. The new announcement is created solely for informational purposes. The tender documents and the procurement notice are published in the old CVP IS, with a direct link provided: https://pirkimai.eviesiejipirkimai.lt/app/rfq/edittransaction.asp?TID=743831. Any clarifications to the tender documents made after 2024-12-01 will be published in this new system. The tender pertains to Ambroxol, a medication commonly used as a mucolytic agent to treat respiratory diseases associated with viscid or excessive mucus. While specific details regarding the quantity, delivery locations, or precise technical specifications are not elaborated in this notice, it is understood that the procurement aims to secure a supply of this pharmaceutical product. Potential bidders are directed to the provided link in the old CVP IS for comprehensive tender documentation, including eligibility criteria, submission guidelines, and evaluation methodologies. The re-announcement serves to ensure continued visibility and compliance with procurement timelines, with future amendments to be managed through the current platform. Interested parties should consult the original tender documents for full details and ensure adherence to all stipulated requirements and deadlines.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Lithuania, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 228,878.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.